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Myosin-X knockout is semi-lethal 
and demonstrates that myosin-X 
functions in neural tube closure, 
pigmentation, hyaloid vasculature 
regression, and filopodia formation
Ernest G. Heimsath Jr.  1, Yang-In Yim2, Mirna Mustapha3, John A. Hammer2  
& Richard E. Cheney1,2
Myosin-X (Myo10) is an unconventional myosin best known for its striking localization to the tips of 
filopodia. Despite the broad expression of Myo10 in vertebrate tissues, its functions at the organismal 
level remain largely unknown. We report here the generation of KO-first (Myo10tm1a/tm1a), floxed 
(Myo10tm1c/tm1c), and KO mice (Myo10tm1d/tm1d). Complete knockout of Myo10 is semi-lethal, with over half 
of homozygous KO embryos exhibiting exencephaly, a severe defect in neural tube closure. All Myo10 
KO mice that survive birth exhibit a white belly spot, all have persistent fetal vasculature in the eye, 
and ~50% have webbed digits. Myo10 KO mice that survive birth can breed and produce litters of KO 
embryos, demonstrating that Myo10 is not absolutely essential for mitosis, meiosis, adult survival, or 
fertility. KO-first mice and an independent spontaneous deletion (Myo10m1J/m1J) exhibit the same core 
phenotypes. During retinal angiogenesis, KO mice exhibit a ~50% decrease in endothelial filopodia, 
demonstrating that Myo10 is required to form normal numbers of filopodia in vivo. The Myo10 mice 
generated here demonstrate that Myo10 has important functions in mammalian development and 
provide key tools for defining the functions of Myo10 in vivo.
Myosin-X (Myo10) is an unconventional myosin expressed in most vertebrate tissues, including brain, testis, kid-
ney, and endothelia1. Despite intense interest in its cellular and biophysical properties2,3, little is known regarding 
the organismal functions of Myo10. Mutant mice have been crucial for understanding the functions of other 
myosins and their roles in human disease, as illustrated by Myo5a in dilute lethal mice and human Griscelli syn-
drome4, Myo6 in Snell’s Waltzer mice and human nonsyndromic deafness5, Myo7a in Shaker-1 mice and human 
Usher 1b deaf-blindness syndrome6,7, and Myo15a in Shaker-2 mice and human deafness DFNB38,9. To fully 
define the functions of Myo10, it is thus essential to generate Myo10 knockout (KO) mice and determine their 
phenotype.
Myo10 is a member of a phylogenetically ancient group of myosins characterized by one or more 
MyTH4-FERM domains (Myosin Tail Homology 4 and band 4.1, Ezrin, Radixin, Merlin). The MyTH4-FERM 
myosins are strongly associated with protrusions based on actin bundles, such as filopodia, microvilli, and inner 
ear stereocilia10,11. Of the four MyTH4-FERM myosins expressed in humans, Myo7a is expressed in several tissues 
and localizes to inner ear stereocilia12, Myo7b is expressed in transporting epithelia and localizes to the tips of 
microvilli13, Myo15a is expressed in the inner ear and localizes to the tips of stereocilia14, and Myo10 is expressed 
in most cells and localizes to the tips of filopodia3.
The heavy chain of full-length mouse Myo10 is encoded by 41 exons that span 191 kb on chromosome 15. 
Myo10 contains 2062 aa (amino acids) that form a head, neck, and tail. The head domain binds to actin filaments 
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and hydrolyzes ATP to generate force and movement3. The neck consists of a light chain binding domain with 
3 IQ motifs, each of which binds to a calmodulin or calmodulin-like light chain. The tail domain begins with a 
stable α-helix15 followed by a short α-helical region that can dimerize by forming an anti-parallel coiled coil2,16. 
The remainder of the tail includes a PEST region, 3 Pleckstrin Homology (PH) domains, and a MyTH4-FERM 
domain1. The second PH domain binds to the important signaling lipid PI(3,4,5)P3, and activation of PI3 kinase 
is thought to recruit Myo10 monomers to the plasma membrane, triggering them to form mechanochemically 
active dimers17–19. The MyTH4 domain can bind to microtubules, allowing Myo10 to act as a motorized link 
between actin filaments and microtubules20–22. The FERM domain can bind to the cytoplasmic domains of several 
cell surface proteins, including β-integrins23 and the netrin receptors DCC (Deleted in Colorectal Cancer) and 
neogenin24. Neogenin is also a coreceptor for Bone Morphogenic Proteins (BMP)25, and Myo10 is upregulated by 
BMP and functions in BMP signaling26,27.
Although most cells and tissues appear to express only the ~237 kD full-length Myo10, neural stem cells, 
neurons, and astrocytes express both full-length and a ~165 kD, “headless” form of Myo1028,29. This work showed 
that use of an alternative transcription start site located ~8.6 kb into intron 19 generates a headless specific exon 
consisting entirely of 5′ UTR and that splicing this to exons 20–41 generates a transcript for headless Myo10. This 
headless transcript (corresponding to NCBI reference sequence XM_192774.2) encodes a protein expected to ini-
tiate at M644 and thus lack most of the motor domain, but is otherwise identical to full-length Myo10. The NCBI 
predicts that two other alternative transcription start sites are located ~13.9 and ~29.5 kb into intron 19 and gen-
erate two additional transcripts for headless Myo10 (XM_006520025.3 and XM_006520024.3). The first encodes 
a headless protein that is identical to the headless protein described above and corresponds to aa 644–2062 of 
full-length Myo10; the second is identical except that it adds a single M preceding aa 644–2062. Headless Myo10 
does not induce filopodia and has been hypothesized to act as a natural dominant negative and/or as a scaffold 
that interacts with Myo10 binding partners such as PIP3, microtubules, and β-integrins29,30.
Full-length Myo10 is strongly associated with filopodia3, finger-like protrusions thought to function in migra-
tion, adhesion, and signaling31,32. In cell culture, overexpressing full-length Myo10 increases filopodia number, 
whereas inhibiting Myo10 decreases filopodia number33–36. Extremely faint particles of GFP-Myo10 within filopo-
dia move rapidly towards the tip at rates of ~600 nm/s37,38, leading to the hypothesis that full-length Myo10 pow-
ers the intrafilopodial transport of candidate cargo molecules like integrins. In vitro studies with Myo10 indicate 
that it is specialized to move on parallel actin bundles and can move processively at rates of over ~600 nm/s2,39. 
Myo10 also functions in microtubule-dependent processes like spindle orientation20,40,41. Growing evidence indi-
cates that Myo10 has important roles in cancer biology. Specifically, Myo10 is upregulated in several cancers, is a 
key component of invadopodia, and inhibiting it suppresses invasion42–45.
By generating mice with combined loss of full-length and headless Myo10, we show that complete loss of 
Myo10 is semi-lethal, with over half of null embryos exhibiting exencephaly. Myo10 null mice that survive birth 
exhibit several abnormalities, and demonstrate that Myo10 is required to form normal numbers of filopodia in 
vivo. Together this work shows that Myo10 has important functions in mammalian development in neural tube 
closure, pigmentation, and regression of the fetal vasculature of the eye.
Results
Generation of Myo10 KO-first, floxed, and KO mice. To generate mice that completely lack all forms 
of Myo10, we began by obtaining C57BL/6 derived embryonic stem cells from the Knockout Mouse Project 
(KOMP) that target exon 27 of Myo10 with a KO-first cassette (www.komp.org; Myo10tm1a(KOMP)Wtsi). The KO-first 
cassette contains a strong splice acceptor site and stop codon upstream of exon 27 that are expected to truncate 
full-length Myo10 and the three headless transcripts after aa 1190 (Fig. 1A,B). The KO-first cassette also contains 
an internal ribosomal entry site (IRES) upstream of lacZ to allow X-gal labeling of cells that express full-length 
or headless Myo10. Because the KO-first cassette is flanked by FRT sites, exposing the Myo10tm1a allele to Flp 
recombinase is expected to excise the KO-first cassette, which should restore Myo10 expression and generate 
the conditional Myo10tm1c allele. Because exon 27 is flanked by loxP sites, exposure of the Myo10tm1c allele to Cre 
recombinase is expected to delete exon 27 and generate a true genomic KO allele (Myo10tm1d).
To obtain germline transmission of the Myo10tm1a allele on a C57BL/6 background, the Myo10tm1a ES cells 
were injected into blastocysts and the resulting chimeras were bred with albino C57BL/6 mice. Offspring carrying 
the Myo10tm1a allele were crossed with C57BL/6 mice expressing FLPo recombinase to excise the KO-first cassette 
and generate the floxed Myo10tm1c allele on a C57BL/6 background. Myo10tm1c mice were then crossed with a 
global Cre-deleter strain (β-actin Cre) on a C57BL/6 background to delete exon 27 and generate the Myo10tm1d 
KO allele. Mice carrying the Myo10tm1d allele were then bred to one another and maintained as a germline KO 
on the C57BL/6 background. As expected, immunoblots of whole brain from P5 pups showed that control 
mice expressed both full-length and headless Myo10, while neither was detected in the Myo10tm1a/tm1a KO-first. 
Removal of the KO-first cassette produced the conditional Myo10tm1c/tm1c and restored expression of full-length 
and headless Myo10, while neither form of Myo10 was detected in the Myo10tm1d/tm1d KO (Fig. 1C).
Myo10 KO mice have ~60% incidence of exencephaly. When heterozygous Myo10+/tm1d mice were 
crossed with one another, pups were obtained at the ratio of 1 Myo10+/+: 2 Myo10+/tm1d: 0.4 Myo10tm1d/tm1d 
(Fig. 2A). This differs from the expected Mendelian ratio of 1:2:1 in that Myo10tm1d/tm1d null pups were obtained 
only ~40% as often as expected (30 Myo10tm1d/tm1d null pups versus 77 Myo10+/+ wild type). Myo10+/tm1d heterozy-
gotes, however, were obtained at the expected 2:1 ratio relative to Myo10+/+ homozygotes and appeared indistin-
guishable from them, thus demonstrating that one copy of the Myo10 gene is sufficient for normal development. 
The lower than expected number of Myo10tm1d/tm1d pups led us to suspect that ~60% of Myo10tm1d/tm1d embryos 
might undergo embryonic or perinatal lethality and not survive to be counted as pups. To test this, we dissected 
pregnant Myo10+/tm1d (n = 4) and Myo10tm1d/tm1d (n = 2) mice that had been mated to Myo10tm1d/tm1d males 
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Figure 1. Generation of Myo10 KO mice. (A) Aligned bar diagrams showing exon boundaries relative to the protein 
domain structure of full-length and headless Myo10. The gene for full-length Myo10 in Mus musculus is located on 
chromosome 15 and contains 41 exons (NCBI Gene ID: 17909). Transcripts for headless Myo10 are produced by use 
of three alternative transcription start sites located in intron 19 followed by splicing to exons 20–41. The Myo10tm1a 
mutation targets exon 27 while the spontaneous Myo10m1J mutation is due to an 8 bp deletion in exon 25. Exons 
of particular interest are shaded black. The protein domain structure includes a myosin motor domain (Head), IQ 
motifs (IQ), stable α-helix (SAH), coiled coil (CC), PEST region, Pleckstrin homology (PH) domains, and a MyTH4-
FERM domain. (B) Design of the Myo10tm1a, Myo10tm1c, and Myo10tm1d alleles. Myo10 expression in the KO-first 
allele (Myo10tm1a) is disrupted due to insertion of a KO first cassette that includes a strong splice acceptor (SA), a stop 
codon, an internal ribosome entry site (IRES), and LacZ upstream of exon 27. Because the KO-first cassette is flanked 
by FRT sites, it can be excised by FLP recombinase, restoring Myo10 expression and generating the conditional 
Myo10tm1c allele. Because exon 27 is flanked by loxP sites, exposure to Cre recombinase deletes exon 27 and generates 
the Myo10tm1d KO allele. Black arrows indicate genotyping primers as described in the Methods. (C) Immunoblot 
of whole brain lysates from P5 mice. As expected, both full-length and headless Myo10 are detected in the wild-type 
C57BL/6 and neither is detected in the KO-first Myo10tm1a/tm1a. Expression of full-length and headless is restored in 
Myo10tm1c/tm1c, and neither is detected in the Myo10tm1d/tm1d KO. Note that at these exposure settings numerous faintly 
stained bands below the molecular weights of full-length and headless Myo10 are visible in the C57BL/6 sample and 
that most of these putative breakdown products are absent in the KO-first Myo10tm1a/tm1a and Myo10tm1d/tm1d KO 
samples. Some non-specifically stained bands are also visible, such as the faint band just below 37 kDa. The signal 
from the same blot stained with anti-actin (43 kDa) is shown in the red channel as a loading control and has been 
overlaid onto the black and white Myo10 signal.
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and examined Myo10tm1d/tm1d embryos between E12.5 and E17.5. Strikingly, 15 of the 22 (68%) Myo10tm1d/tm1d  
embryos exhibited exencephaly (Fig. 2B), a severe defect in neural tube closure that is incompatible with sur-
vival after birth46. Because over half of Myo10tm1d/tm1d embryos were exencephalic, these results reveal that Myo10 
Figure 2. Myo10tm1d/tm1d KO mice have a white belly spot and persistent hyaloid vasculature plus a high 
frequency of exencephaly, webbed digits, and other abnormalities. (A) Total number of pups obtained for each 
genotype from heterozygous matings showing that homozygous nulls are obtained at less than half the expected 
number (n = 42 litters, 260 pups total, mean litter size 6.1). (B) E14.5 embryos showing a normal Myo10+/+ 
control and an exencephalic Myo10tm1d/tm1d littermate. Note that the Myo10tm1d/tm1d embryo also exhibits 
microphthalmia. (C) Adult mice showing an example of the white belly spot observed in all Myo10tm1d/tm1d mice 
(white arrow). (D) Left forepaws from adult mice showing an example of the webbed digits observed in ~50% 
of Myo10tm1d/tm1d mice. (E) Eyecups from 6-week-old mice showing a control eye from a wild-type mouse and 
an example of the pigmented mass present in Myo10tm1d/tm1d mice (black arrow). For each eye, the cornea, iris 
and lens were dissected away and then four incisions were made in each eyecup (dotted lines) to allow the lens 
to be carefully removed and the eyecup to be partially flattened. (F) Tails from adult mice showing an example 
of a kinked tail in a Myo10tm1d/tm1d mouse. Kinked tails were present in most Myo10tm1d/tm1d mice, but were often 
much more subtle.
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has important functions in neural tube closure, and that combined loss of full-length and headless Myo10 is 
semi-lethal.
Myo10 KO mice have a white belly spot and a high frequency of syndactyly. We next investigated 
the phenotype of the ~40% of Myo10tm1d/tm1d mice that survived birth. The average weight at weaning (P21) was 
7.6 g ± 2.1 for Myo10tm1d/tm1d (n = 9), which is slightly smaller than the 9.8 g ± 1.0 for Myo10+/+ (n = 4, p = 0.026) 
and 9.9 g ± 1.1 for Myo10+/tm1d (n = 9, p = 0.01). A similar difference was also observed at P28 (Supplementary 
Figure 1). KO pups were able to nurse, feed, and mature into adults. Strikingly, 100% of the Myo10tm1d/tm1d mice 
exhibited a white spot on the belly instead of the uniform black coat expected for C57BL/6 mice (Fig. 2C). 
Additional pigmentation defects, such as a white spot on the back, were observed in a few cases. The belly spot 
was noticeable as soon as black pigmentation developed elsewhere and provided a simple visual screen to confirm 
the PCR genotyping of Myo10 null mice. ~50% of Myo10tm1d/tm1d mice exhibited webbed digits, a form of syndac-
tyly, with the webbed digits usually affecting the forelimb (Fig. 2D). Approximately 75% of Myo10tm1d/tm1d mice 
exhibited a visible kink near the tip of the tail (Fig. 2F). 53% of the homozygous Myo10tm1d/tm1d mice obtained 
were male, and Myo10tm1d/tm1d homozygotes were able to develop into mature adults that could mate with one 
another to produce Myo10tm1d/tm1d embryos and pups. This demonstrates that meiosis and mitosis can occur in 
the complete absence of Myo10, and that embryonic development can occur in the absence of maternal Myo10. 
Young adult Myo10tm1d/tm1d mice did not exhibit obvious movement defects like circling or shaking and responded 
to a hand clap by flicking their ears (Preyer reflex), indicating that hearing and balance are grossly intact at this 
age. The oldest Myo10tm1d/tm1d mice have survived over a year and a half without obvious morbidity or mortality. 
Together these results demonstrate that Myo10 has important roles in mammalian development, but is not strictly 
essential for adult survival or fertility.
Myo10 KO mice have persistent hyaloid vasculature. Dissection of eyes from adult mice followed by 
careful removal of the lens revealed that a black, pigmented mass was present bilaterally in all 11 Myo10tm1d/tm1d  
mice tested but none of 14 Myo10+/+ or Myo10+/tm1d mice (Fig. 2E) The mass was typically attached to the optic 
disc by a thin strand and extended through the vitreous to form a plexus on the posterior surface of the lens. In 
some eyes, the retrolental mass appeared to have integrated into the retina and disrupted the retina’s normal mor-
phology. The position and morphology of the retrolental mass indicate that it is persistent hyaloid vasculature. 
This condition is also known as persistent fetal vasculature (PFV) or persistent hyperplastic primary vitreous 
(PHPV), and results from a hyperplasia and persistence of a normally transient fetal vasculature that perfuses 
the vitreous during development47. The hyaloid vasculature originates at the optic disk as the stalk of the hya-
loid artery and includes numerous branches, some of which extend through the periphery of the vitreous while 
others form a plexus on the posterior surface of the lens. The hyaloid vasculature in mouse begins forming at 
approximately E12.5 as the optic fissure closes, and is normally resorbed over the first few postnatal weeks as the 
retinal vasculature grows out onto the surface of the retina and matures. In humans, PFV is responsible for 5% of 
childhood blindness and is associated with increased incidence of several other ocular abnormalities including 
microphthalmia (a small eye)47. When a series of 11 Myo10tm1d/tm1d E12.5-E14.5 embryos were examined for 
major eye defects, 3/11 exhibited severe microphthalmia and 2/11 exhibited anophthalmia (absence of an eye).
To investigate the development of the persistent hyaloid vasculature, we dissected eyes from pups at P5, a 
time when the hyaloid vasculature would have just started to resorb. The retinal vasculature, on the other hand, 
would have begun angiogenesis at ~P0 by growing out from the optic disc and by P5 should extend approximately 
halfway across the retina48. Dissection revealed that a pigmented mass (Fig. 3A) was present bilaterally in 17 
Myo10tm1d/tm1d mice, while no examples were present in any of the eyes from 12 control mice. Immunofluorescence 
with the endothelial cell marker PECAM-1 (CD31) showed that numerous long and relatively straight hyaloid 
vessels were present in the control eye at P5; as expected, the hyaloid vessels originated near the optic disk and 
extended branches towards the ciliary body (Fig. 3B). In the Myo10tm1d/tm1d retina, however, the hyaloid artery 
extended as a thickened stalk from the optic disk into a pigmented mass. The pigmented mass includes a plexus 
of blood vessels and pigment cells, with long and relatively straight hyaloid vessels extending outward from arms 
on the mass toward the ciliary body. The presence of the pigmented mass at P5 demonstrates that it forms and 
becomes pigmented prior to the major regression of hyaloid vessels in control eyes. Pigmented cells were not 
observed on either the stalk of the hyaloid artery or the hyaloid vessels extending towards the ciliary body, both of 
which represent potential pathways for pigment cell migration (Fig. 3B,D). Together these experiments demon-
strate that a core element of the Myo10tm1d/tm1d phenotype is 100% penetrance of persistent hyaloid vasculature 
that is pigmented and bilateral.
Myo10 KO-first mice also exhibit a high incidence of exencephaly, a white belly spot, and reten-
tion of the hyaloid vasculature. In addition to determining the phenotype of the definitive germline 
KO mice, we also investigated the phenotype of the KO-first mice (Myo10tm1a/tm1a). Myo10+/tm1a heterozygotes 
appeared indistinguishable from controls, but when they were crossed to each other, pups were obtained at the 
ratio of 1 Myo10+/+: 1.5 Myo10+/tm1a: 0.45 Myo10tm1a/tm1a (20 Myo10+/+, 30 Myo10+/tm1a, 9 Myo10tm1a/tm1a; n = 9 
litters). Because Myo10tm1a/tm1a homozygotes were obtained only 45% as often as Myo10+/+ homozygotes, these 
results again suggested that loss of Myo10 was leading to a high frequency of embryonic or perinatal lethal-
ity. Consistent with this, examination of Myo10tm1a/tm1a E12.5 embryos resulting from 2 homozygous crosses of 
Myo10tm1a/tm1a mice revealed that 50% (9/18) had exencephaly. Myo10tm1a/tm1a homozygotes that survived birth 
grew to adulthood and 100% had a white belly spot. A few also had additional pigmentation defects such as 
a white spot on the back. 100% of Myo10tm1a/tm1a mice whose eyes were dissected (5/5) had persistent hyaloid 
vasculature that was pigmented and bilateral. Approximately 50% of Myo10tm1a/tm1a mice had webbed digits and 
similar fraction had a kink near the tip of the tail. Importantly, when the KO-first mice were crossed with FLPo 
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Figure 3. Eyes from Myo10tm1d/tm1d KO mice have persistent hyaloid vasculature. (A) Eyecups from P5 mice 
showing a control eye from a wild-type mouse and an example of the pigmented persistent hyaloid vasculature 
present in a Myo10tm1d/tm1d mouse. The white spot in the center of each eye is the optic disk. An irregular 
black mass is located above and to the right of the optic disc in the Myo10tm1d/tm1d eye. (B) The same eyecups 
in (A) were fluorescently stained with a PECAM-1 antibody (green) to label endothelial cells. In the control 
at left, several long and relatively straight branches (dotted white arrow) of the hyaloid vasculature can be 
seen extending from their origin near the optic disk towards the rim of the eyecup. Consistent with their 
identification as hyaloid vasculature, they are located within the vitreous and slightly above the developing 
retinal vasculature, which forms reticulum on the surface of the retina (solid white arrow). In the Myo10tm1d/tm1d 
eye, a relatively thick hyaloid artery extends from the optic disk to the pigmented mass, while long and relatively 
straight branches of the hylaloid vasculature extend outward from arms of the pigmented mass. Because the 
eyecups curve upwards at their outer edges, the view there is foreshortened. The hyaloid and retinal vasculatures 
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mice to delete the KO-first cassette, Myo10 expression was restored (Fig. 1C) and the resulting Myo10tm1c/tm1c mice 
appeared completely normal. This rescue of the KO-first phenotype provides strong genetic evidence that the 
phenotypes reported here are specifically due to disruption of Myo10.
Myo10 is required to form normal numbers of filopodia during retinal angiogenesis. Given in 
vitro studies indicating that Myo10 is a key component of filopodia3 we next sought to determine if Myo10 is 
required for filopodial formation in vivo. Therefore, we turned to the retinal vasculature, where endothelial tip cells 
generate numerous filopodia during angiogenesis as they grow out across the retina48,49. To visualize the endothe-
lial cells and their filopodia, P5 retinas were stained with a PECAM-1 antibody (Fig. 4A). Low power views 
showed that the retinal vasculature grew similar distances across the retina in both control and Myo10tm1d/tm1d  
retinas (1.34  ± 0.11 mm for 9 controls and 1.25  ± 0.08 for 5 Myo10tm1d/tm1d, p = 0.09), demonstrating that angio-
genic outgrowth can occur in the absence of Myo10. The vascular network, however, appeared to be less dense in 
Myo10tm1d/tm1d retinas, and quantification showed that the branches/mm2 decreased by over 30% (Fig. 4A,C). To 
determine if loss of Myo10 decreased filopodia, we collected Z-stacks of the vascular front at 60x and displayed 
these as maximum projections. This revealed that the endothelial cells in Myo10tm1d/tm1d retinas had far fewer 
filopodia than controls (Fig. 4B). Quantification showed a ~50% decrease in filopodia per mm along the vascular 
front (Fig. 4D), thus demonstrating that Myo10 is required to form normal numbers of filopodia in vivo.
Myo10m1J/m1J mice exhibit exencephaly, a white belly spot, and retention of the hyaloid vascu-
lature. To conclusively define the phenotype resulting from loss of full-length and headless Myo10, we also 
examined mice carrying an independent mutation (Myo10m1J) that was recently listed along with 91 other new 
mouse mutations identified at The Jackson Laboratory50. The Myo10m1J mutation, which is on a C57BL/6 back-
ground, is due to a spontaneous 8 bp deletion (CGACGAGT) in exon 25 and produces a frame shift expected to 
truncate full-length Myo10 and all three headless transcripts following aa 948. The brief online description of the 
Myo10m1J mutation (http://www.informatics.jax.org/reference/J:214794) indicates that homozygotes exhibited a 
white belly spot. Syndactyly on the forelimbs was also noted, and persistent fetal vasculature was visible in the two 
mice whose eyes were examined. Homozygous Myo10m1J/m1J mice were listed as viable, but as having a decreased 
body size. However, no immunoblots were performed to confirm loss of Myo10 protein, no data was presented on 
the proportion of homozygotes obtained, and no mention was made of exencephaly.
Immunoblots of whole brain from a month-old Myo10m1J/m1J mouse show that neither full-length nor headless 
Myo10 was detected, demonstrating that the mutation results in complete loss of Myo10 (Fig. 5A). Myo10+/m1J  
heterozygotes appeared normal, but when they were mated to one another, pups were obtained in the ratio of 
1 Myo10+/+: 2.3 Myo10+/m1J: 0.3 Myo10m1J/m1J (Fig. 5B). The much lower than expected number of Myo10m1J/m1J 
pups (14 Myo10m1J/m1J nulls versus 48 Myo10+/+) again suggested that loss of Myo10 leads a high level of embry-
onic or perinatal lethality. Analysis of embryos (E12.5-E17.5) from heterozygous matings revealed that 22/88 
(25%) were Myo10m1J/m1J homozygotes, indicating that null embryos were present in the expected Mendelian 
percentage. Examination of the 22 null embryos revealed that 73% had exencephaly (Fig. 5C), 18% had craniora-
chischisis (a major failure of neural tube closure at the level of the hindbrain and spinal cord), and 9% had a gross 
developmental defect such as very small size. This demonstrates that a large fraction of Myo10m1J/m1J embryos 
have exencephaly and/or other defects that would be incompatible with survival past birth. Examples of fetuses 
undergoing resorption were also observed, and 64% of homozygous embryos exhibited blood in the amniotic 
fluid. Homozygous embryos appeared slightly smaller than controls, even when not affected by exencephaly or 
other major defects.
Of the 14 homozygous Myo10m1J/m1J pups obtained above, 6/14 were male, 14/14 had a white belly spot, 4/14 
also had a white spot on the back, 6/14 had webbed digits on one or both forelimbs (Fig. 5D). Kinked tails 
were not obvious in Myo10m1J/m1J mice and were not scored due to the difficulty of defining very mild kinks. 
Anophthalmia was present in 1/14 of the Myo10m1J/m1J mice and 3/14 had severe microphthalmia. All 5 of the 
Myo10m1J/m1J homozygotes whose eyes were dissected at 6 weeks had persistent hyaloid vasculature, and this 
was pigmented and present bilaterally (Fig. 5E). The average weight at weaning (P21) for Myo10m1J/m1J pups 
was 8.5 ± 1.5 g (N = 7), which is slightly smaller than the 11.3 ± 0.7 g for Myo10+/m1J (N = 38, p = 0.00002) and 
11.6  ± 0.5 g for Myo10+/+ (N = 18; p = 0.00002). Similar results were obtained at P28 (Supplementary Figure 1). 
Myo10m1J/m1J homozygotes that survived birth were able to feed and develop into adults. Young adult homozy-
gotes did not exhibit obvious circling or shaking and responded to a clap by flicking their ears. Homozygotes 
could successfully mate, and analysis of the 8 E15.5 embryos obtained from a homozygous mating revealed that 
1 was very small and appeared to lack a liver while 7 had exencephaly, including one that also had omphalocele 
(protrusion of abdominal organs outside the abdominal wall). All 8 embryos also exhibited blood in the amniotic 
sac, although this intra-amniotic hemorrhage may have been secondary to the major developmental defects like 
exencephaly. Together these results demonstrate that the phenotypes of the spontaneous Myo10m1J/m1J mutation 
are very similar to those of the targeted Myo10tm1a/tm1a and Myo10m1d/m1d mutations, although the Myo10m1J/m1J 
phenotype may be somewhat more severe.
can be best distinguished by enlarging the images on a digital display. (C) Schematic cross-section of a normal 
P5 eye. At this stage the hyaloid vasculature has begun to regress, but still perfuses the vitreous and forms a 
plexus on the posterior of the lens, while the retinal vasculature is undergoing angiogenesis and extending on 
the surface of the retina. Illustration created by EGH. (D) Close-up view of the pigmented mass in (A) and (B) 
showing that it includes a dense plexus of hyaloid vasculature intermixed with pigment cells. The plexus can be 
seen most clearly after enlargement on a digital display.
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Figure 4. Loss of Myo10 decreases the number of filopodia during retinal angiogenesis. (A) Fluorescence 
image of flat mounted retinas showing retinal vasculature at P5. Dissected retinas were stained with a PECAM-1 
antibody (green) and counterstained with phalloidin (red). The retinal vasculature extended to similar positions 
in control and Myo10tm1d/tm1d eyes. The image represents a stitch of micrographs taken at 20X and is best 
visualized if the images are enlarged on a digital display. (B) High resolution images of the angiogenic expansion 
front from the P5 retinas in (A) showing filopodia radiating from endothelial tips cells. Loss of Myo10 results in 
a decreased number of filopodia and leads to a less dense vascular network. Images were captured as Z-stacks 
at 60X and displayed as maximum projections with the PECAM-1 channel displayed in inverted grayscale 
to highlight endothelial filopodia. (C) Quantification showing that loss of Myo10 decreases the branch point 
density/mm2 by 32%. (D) Quantification showing that loss of Myo10 decreased the number of filopodia per mm 
of vascular front by ~50%. N = 3 mice for both (C) and (D) and error bars denote standard deviation.
www.nature.com/scientificreports/
9SCientifiC REPORTS | 7: 17354  | DOI:10.1038/s41598-017-17638-x
Figure 5. Myo10m1J /m1J mice have a white belly spot and persistent hyaloid vasculature plus a high frequency of 
exencephaly and other abnormalities. (A) Immunoblot of whole brain lysates from 1 month old mice showing 
deletion of full-length and headless Myo10. Although bands corresponding to full-length and headless Myo10 
are absent in the Myo10m1J /m1J lysate, it should be noted that the Myo10 antibody shows some non-specific 
staining, including one band that is slightly larger than headless and another that is near the 100 kDa standard. 
The signal from the same blot stained with anti-actin (43 kDa) is shown in the red channel as a loading control 
and has been overlaid onto the black and white Myo10 signal. (B) Total number of pups obtained for each 
genotype from heterozygous matings showing that Myo10m1J /m1J homozygotes were obtained at less than 
half the expected number (n = 28 litters, 174 pups total; mean litter size 6.2). (C) E15.5 embryos showing 
a Myo10+/+ control and an exencephalic Myo10m1J /m1J littermate. (D) Adult Myo10m1J/m1J mouse showing 
examples of a white belly spot, a white spot on the back, and syndactyly. (E) Eyecups from 6-week old mice 
showing a normal eye from a Myo10+/+ mouse and an example of the pigmented mass of persistent hyaloid 
vasculature present in the eyes of Myo10m1J/m1J mice. (F) Rostral coronal sections from E16.5 embryos showing 
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To further investigate the defects resulting from loss of Myo10, hematoxylin and eosin stained sections were 
prepared from the heads of control and Myo10m1J/m1J embryos at E16.5 (Fig. 5F). Rostral coronal sections show 
relatively normal development of the brain and cranium in Myo10m1J/m1J embryos that were not exencephalic, as 
well as the absence of a cranium and gross defects in brain morphology in an exencephalic embryo. Higher mag-
nification views of Myo10m1J/m1J eyes at E16.5 revealed examples of abnormally large numbers of cells behind the 
lens, as expected for the development of persistent hyaloid vasculature. Myo10m1J/m1J eyes also revealed examples 
of other abnormalities that are often associated with persistent hyaloid vasculature, such as defects in lens for-
mation. We also observed examples of failed embryonic eyelid closure (Figs 5F3′ and 4′), a process that normally 
occurs at E15.5–16.5 when sheets of eyelid cells extend across the eye and fuse51. This defect or delay in eyelid clo-
sure was observed both in exencephalic and non-exencephalic Myo10m1J/m1J embryos, demonstrating that it is not 
secondary to exencephaly. Taken together, the results here define the core phenotype resulting from complete loss 
of full-length and headless Myo10. They also demonstrate that Myo10 has important roles in neural tube closure, 
pigmentation, regression of the fetal vasculature of the eye, and filopodia formation.
Discussion
Myo10 functions in filopodia formation and angiogenesis in vivo. A key feature of Myo10 deduced 
from studies in cell culture is its roles in filopodia – Myo10 induces filopodia, traffics within filopodia, and local-
izes to filopodial tips3. We show here that the angiogenic front in Myo10 KO retinas exhibits ~50% fewer filopodia 
than controls, thus demonstrating that Myo10 functions in filopodia formation in vivo. Because we have previ-
ously shown that endothelial cells in culture express full-length Myo10, and that Myo10 knockdown decreases 
filopodia number26, it is likely that the decreased filopodia in KO retinas is cell autonomous and due to the loss 
of the filopodia-promoting activity of full-length Myo10. Our results also reveal that some filopodia are able to 
form in the complete absence of Myo10, which demonstrates the existence of a Myo10 independent pathway for 
filopodia formation. Our results on filopodia formation in vivo are also consistent with recent results showing 
that macrophages cultured from a different Myo10 KO mouse exhibit greatly decreased filopodia formation36. 
A description of the KOMP-generated Myo10tm2/tm2 mouse has not yet been published, but the allele includes a 
9.5 kb deletion that disrupts exon 19 and is expected to delete full-length Myo10 and the first of the three headless 
transcripts. Although the slender protrusions that form in the absence of Myo10 have a filopodial morphology, it 
should be kept in mind that they may differ from normal filopodia. In the future, it will be important to investi-
gate their composition and dynamics and to determine if they lack components reported to interact with Myo10, 
such as β-integrins23 and VE-cadherin52. Interestingly, knockout of fascin, the major actin bundling protein in 
filopodia, also decreases filopodia without completely eliminating them53,54. The ability of filopodia to form in 
the complete absence of either their major actin bundling protein or the molecular motor Myo10 suggests that 
filopodia formation is a robust process with substantial redundancy.
Because the vasculature in control and Myo10 KO mice grew out to similar positions on the retina by P5, 
neither Myo10 nor a full complement of filopodia were essential for endothelial outgrowth. Loss of Myo10 did 
reduce the density of branch points by ~30%. This suggests that Myo10 and filopodia may be more important 
for forming branches and cell-cell contacts than for outgrowth per se. Somewhat similar results were reported 
in zebrafish angiogenesis when filopodia formation was completely eliminated using a low dose of the anti-actin 
drug latrunculin55. Under those conditions, developing vessels were still able to grow in the proper direction 
using lamellipodia, but they exhibited defects in their ability to connect to one another. Loss of Myo10 may well 
have additional effects on vascular patterning, and given the importance of angiogenesis in development, cancer, 
and eye disease, further investigation of the roles of Myo10 and filopodia in angiogenesis is warranted.
Myo10 functions in neural tube closure. In all three strains of null mice, half or more of the embryos 
exhibited exencephaly. Exencephaly is a severe neural tube defect resulting from failure to close the neural tube 
at the cranial level46. Neural tube defects are a leading cause of human birth defects, affecting 300,000 births per 
year worldwide56. Exencephaly constitutes one third of all neural tube defects and leads to a defect in cranium 
formation and exposure of the brain to amniotic fluid. In both mouse and human, neural tube closure initiates 
at the boundary between the developing hindbrain and spinal cord. Failure of this initial closure is associated 
with mutations in the canonical Wnt-frizzled planar cell polarity pathway and results in craniorachischisis, while 
failure to close the neural tube at the midbrain or its anterior end results in exencephaly46. Because we observed 
a high incidence of exencephaly and only occasional examples of craniorachischisis, Myo10 is most crucial for 
neural tube closure at the cranial level. Given that exencephaly is incompatible with survival after birth and was 
observed in half or more Myo10 null embryos, we conclude that exencephaly is the major cause of death in Myo10 
nulls. Most importantly, our results reveal a previously unsuspected requirement for Myo10 in neurulation.
a wild-type, two nulls that did not have exencephaly, and one null that did have exencephaly. Note the relatively 
normal appearance of the brain and cranium in the null embryos without exencephaly and the lack of a cranium 
and gross defects in brain morphology in the embryo with exencephaly. The null embryo on the left was selected 
for sectioning in part because it had normal sized eyes while the two embryos on right had microphthalmia. 
Note that slight differences in the plane of section between the left and right side of the skull make some of the 
eyes on the right side appear smaller than they actually are. Higher magnification images of sections through 
the middle of the eyes showing the abnormal accumulations of cells (white arrows) behind the lens and defects 
in lens development in the two eyes on the right (at this stage the lens should be visible as red stained sphere). 
Note also that the null eyes in 3′ and 4′ failed to undergo eyelid closure (black arrows), a process that normally 
occurs between E15.5 and E16.5.
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Exencephaly can result from defects in several processes, including proliferation of neural plate cells, 
morphogenesis of the neural folds, and failure of the neural folds to contact one another and fuse to form a 
tube. Myo10 mRNA is reported to be enriched in the neural plate and cranial neural crest in Xenopus, and 
morpholino-mediated knockdown in Xenopus resulted in craniofacial abnormalities57,58. Our results conclusively 
demonstrate that Myo10 functions in mammalian neural tube closure, but it is not yet clear whether closure 
requires full-length Myo10, headless Myo10, or both forms. Headless Myo10 is expressed in neural stem cells29 
and could act either on its own or by antagonizing the actions of full-length Myo10 in processes such as spin-
dle orientation or filopodia formation. Since filopodia-like protrusions have been observed extending from the 
cranial neural folds and are hypothesized to help the folds contact and fuse59, the filopodia-promoting activities 
of full-length Myo10 are strong candidates to facilitate the contact and zippering stages of neural tube closure. 
Knockouts of other pro-filopodial proteins have been reported to result in exencephaly, as illustrated by the 
Mena/VASP/Evl triple KO60. No Mena/VASP/Evl triple KO mice survived birth, but the embryos were reported 
to exhibit defects such as intraamniotic hemorrhage and a high frequency of exencephaly. Filopodia are known 
to be very sensitive to low doses of cytochalasin61, and exposure to this anti-actin drug during neural tube clo-
sure induces exencephaly62,63. In addition to Myo10’s activities in filopodia formation and spindle orientation, 
it could also act in the signaling pathways required for neural tube closure. This is especially true given that 
Myo10 binds to neogenin24, a receptor for Repulsive Guidance Molecule a (RGMa) and a co-receptor for Bone 
Morphogenic Proteins (BMP)25, and that knockdown of neogenin results in 100% exencephaly64, while deletion 
of RGMa results in 50% exencephaly65.
Since most Myo10 null embryos that succeeded in closing the neural tube developed into viable adults, neural 
tube closure is the critical point for Myo10 function during development. It is not clear why the exencephaly is 
partially penetrant, but variation in genetic background can be ruled out since the Myo10m1J/m1J null mice were on 
a congenic C57BL/6 background. Partial penetrance has recently been shown to be extremely common among 
many mouse traits66 and is generally attributed to stochastic variation in processes such as gene expression and 
subtle differences in the environment. It is also not clear why some aspects of the phenotype such as the exen-
cephaly appear to differ in their penetrance between the different Myo10 alleles. Some of this may be attributable 
to random variation associated with the sample sizes. It is also possible that Myo10tm1d/tm1d and Myo10m1J/m1J dele-
tions produce trace amounts of truncated Myo10 that are below our detection threshold for blotting and that the 
different lengths of Myo10 they would encode (aa 1–948 versus aa 1–1190) influence the penetrance. Although 
the work here defines the core Myo10 phenotype in C57BL/6 mice, it should be kept in mind that the phenotype 
may differ in other species or genetic backgrounds. In the future, it will be important to determine which forms 
of Myo10 are required for neural tube closure, the precise functions of Myo10 in closure, and if exencephaly in 
humans is associated with mutations in Myo10.
Myo10 is required for normal pigmentation. All three Myo10 null mutations characterized here exhib-
ited 100% penetrance of a white belly spot. Moreover, other pigmentation defects such as a white spot on the back 
were observed at lower penetrance. White spots on the belly or chest are present in several types of mutant mice, 
and are also frequently present in cats, dogs, and other domestic animals67. Such unpigmented regions are usually 
due to a defect in the production and/or migration of melanoblasts – neural crest derivatives that must migrate 
long distances to reach the ventral surface where they differentiate into melanocytes. Migrating neural crest cells 
are highly filopodial68 and mice lacking the filopodia-promoting proteins fascin69 or Cdc42 have white belly 
spots70. Since only full-length Myo10 is detected in mammalian melanocytes27, it is likely to act by promoting 
filopodia and facilitating melanocyte migration.
Full-length Myo10 and filopodia have also been hypothesized to function in the transfer of melanosomes from 
melanocytes to skin keratinocytes based on cell culture experiments with human cells27,71. In Myo10 null mice, 
however, most of the coat remains black and does not exhibit the pigmentary dilution due to defects in mela-
nosome positioning and transfer seen in dilute/Myo5a4, ashen/Rab27a72, and leaden/Mlph mice73. The fact that 
most of the coat in Myo10 nulls remains black argues that Myo10 is not essential for melanosome transfer from 
melanocytes to keratinocytes in vivo, at least in mice.
Myo10 is required for regression of the fetal vasculature in the eye. In the three strains of Myo10 
KO mice characterized here, all of the eyes that were examined had persistent hyaloid vasculature, a normally 
transient vasculature that nourishes the developing eye74. PFV is often associated with increased incidence of 
other ocular defects including microphthalmia, coloboma (a failure to properly close the optic fissure), corneal 
opacity, lens-cornea fusion, cataract, retinal folds, retinal detachment, glaucoma, and phthisis (a shrunken, atro-
phied eye)75. Regression of the hyaloid vasculature occurs in the first few weeks after birth in mouse and is a 
poorly understood process that involves macrophages secreting Wnt7b, a death signal for hyaloid endothelial 
cells76,77. Regression of the fetal vasculature also requires that retinal neurons upregulate VEGFR-2 to decrease 
levels of the endothelial survival factor VEGF78. Because Myo10 is expressed in neurons, endothelial cells, mac-
rophages, and melanocytes26,29,79,80, loss of Myo10 could act in several ways, including stimulating an early hyper-
plasia of hyaloid cells, blocking recruitment of macrophages and apoptosis, and/or blocking filopodia-mediated 
signaling by Wnts or other factors.
Pigmented PFV, along with increased incidence of microphthalmia, have also been reported in a conditional 
KO of the Wnt receptor Frizzled 581. Pigmented PFV has been described in mice null for the Arf tumor suppressor 
gene82. The two obvious sources for pigmented cells in the eye would be the retinal pigmented epithelium, which 
is derived from the neuroectoderm and optic cup, and the melanocytes of the choroid, which are derived from 
the neural crest. KO of the guidance molecule Ephrin-A5 also results in pigmented hyaloid vasculature and a high 
frequency of ocular defects, and in this case, the pigmented cells arrive shortly after birth and appear to be derived 
from choroidal melanocytes83. Recent work indicates that the initial cause of persistent hyaloid vasculature may 
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be a defect or delay in the closure of the optic fissure84. Optic fissure closure involves both the fusion of epithe-
lial sheets and apoptosis and shares many features with neural tube closure85. This observation, together with 
instances of failed eyelid closure, suggest that Myo10 facilitates the fusion of epithelial sheets. Filopodia have been 
shown to help epithelial sheets zipper together during Drosophila dorsal closure86, so Myo10’s ability to induce 
filopodia may allow it to facilitate tissue fusion events in vertebrate development.
Although most cases of PFV in humans are unilateral and non-syndromic, approximately 10% are bilateral 
and associated with other abnormalities87. Several human syndromes with bilateral PFV have been identified, 
including Norrie disease, a disease due to defective Wnt signaling that is often associated with vascular defects, 
deafness, and developmental delay88. Because bilateral PFV is a prominent feature of the Myo10 null phenotype, 
MYO10 should be considered a candidate gene for syndromic bilateral PFV in humans.
Other eye defects. In addition to 100% incidence of bilateral PFV, examples of several other eye defects 
were observed in Myo10 null mice. These included examples of anophthalmia, microphthalmia, and defects in 
lens development. The MGI database indicates that in the two Myo10m1J/m1J mice that were examined, defects in 
optic fissure closure were present in two eyes, a thick and cloudy cornea was present in one, and a lens spot was 
present in one. Given the strong association between PFV and eye defects, some of the eye defects in Myo10 null 
mice may be secondary to PFV. The 100% incidence of PFV in Myo10 null mice makes them attractive models for 
investigating the mechanisms that underlie PFV and other eye defects.
Webbed digits and kinked tails. All three Myo10 null mutations characterized here exhibited ~50% 
penetrance of webbed digits, usually on the forelimbs. Vertebrate digits develop embryologically from fin-like 
structures, with the tissue between the digits removed by apoptosis. Apoptosis in the developing limb is induced 
in part by BMP signaling, and BMPs are also involved in skeletogenesis89. Although Myo10 has not previously 
been implicated in apoptosis, Myo10 is upregulated by BMP26,27 and binds to neogenin, a co-receptor for BMP25. 
Many Myo10tm1d/tm1d and Myo10tm1a/tm1a mice exhibited a small kink in the distal part of the tail. Although the 
basis for this defect is unknown, the mutation known as kinked tail is associated with a defect in notochord 
development90. Kinked tails along with craniorachischisis are also present in looptail/Vangl2 mutants91 a compo-
nent of the wnt-frizzled planar polarity pathway, and kinked tails are also present in deletions of Sfrp2 (secreted 
frizzled-related protein 2)92.
Hearing. The MyTH4-FERM myosins Myo7a and Myo15a localize to stereocilia and are required for hear-
ing in human and mouse, raising the question of whether Myo10 is required for hearing. Myo10 mRNA is 
expressed in inner ear hair cells93, but unlike Myo7a and Myo15a, GFP-Myo10 failed to localize to stereocilia94. 
The Jax database indicates that the two Myo10m1J/m1J homozygotes tested for auditory brainstem responses had 
elevated thresholds at all frequencies tested, although the size of this effect was not reported. In the young adult 
Myo10 null mice examined here, hearing and balance appeared grossly intact based on the presence of the 
Preyer reflex and the absence of circling. It is possible that older Myo10 mice exhibit a more severe hearing loss, 
but this is difficult to test in C57BL/6 mice since they already carry a Cdh23 mutation that causes age-related 
hearing loss95.
Myo10 is not absolutely essential for mitosis or meiosis. An intriguing property of Myo10 is that it 
can bind directly to microtubules via its MyTH4 domain20–22. Knockdown and dominant negative experiments 
in cell culture and Xenopus show that Myo10 has several functions associated with microtubules, including spin-
dle assembly and spindle orientation20,41,96. Because embryos can form in the complete absence of Myo10 and 
some survive to adulthood and breed, our results demonstrate that Myo10 is not absolutely essential for either 
mitosis or meiosis. This being said, loss of Myo10 may have more subtle impacts on mitosis, meiosis, or spindle 
orientation, and these could potentially contribute to the phenotypes reported here. Other proteins may partially 
compensate for the loss of Myo10, especially given that Myo10 and dynein have been shown to have partially 
overlapping functions in spindle orientation41. It is also possible that the requirements for Myo10 in mitosis differ 
between cell culture, Xenopus, and mouse. Knockdown of Myo10 in cell culture is also reported to have much 
more severe effects on mitosis in cancer cells than in normal cells97 due to Myo10’s role in clustering the excess 
centrosomes that are a hallmark of cancer cells.
Conclusion and future directions. The analyses of the three Myo10 null mouse strains reported here 
define the major phenotypes resulting from the complete loss of Myo10. Importantly, these analyses show that 
Myo10 is required for production of normal numbers of filopodia in vivo and for normal vertebrate development. 
Future efforts should be directed at determining the molecular mechanisms by which Myo10 functions in cellular 
processes such as filopodia formation and in organismal processes such neural development, pigmentation, and 
eye development. Our creation here of a conditional Myo10 KO allele should greatly facilitate such investigations. 
Finally, it will also be important to investigate Myo10’s functions in signaling, especially given Myo10’s ability 
to bind receptors like DCC and neogenin, as well as growing evidence that filopodia help mediate signaling by 
BMPs, Wnts, and other morphogens98. The mice reported here provide key tools to investigate these and many 
other questions.
Methods
Mouse strain generation. All experiments and procedures involving mice at UNC, Stanford, and the 
NIH were approved and performed in accordance with the guidelines and regulations set forth by the UNC 
Institutional Animal Care and Use Committee (protocol 15–207), the Stanford Institutional Animal Care and 
Use Committee (protocol 23001), and the NIH Office of Animal Care and Use (protocol H-0269R1), respectively. 
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The Myo10tm1a, Myo10tm1c, and Myo10tm1d mouse strains used in this research project were generated from ES cell 
clone EPD0332_3_B02 obtained from the KOMP repository (www.komp.org) and generated by the Wellcome 
Trust Sanger Institute. These ES cells (Myo10tm1a(KOMP)Wtsi, project CSD50217) were generated from parental 
JM8A1.N3 ES cells and are thus derived from a C57BL/6 N mouse. The Myo10-targeted ES cells use a promo-
tor driven L1L2_Bact_P cassette that inserts an FRT site, a strong splice acceptor, an IRES, lacZ, a poly A site, a 
β-actin promotor, Neo resistance, and a FRT site in the intron immediately preceding exon 27, as well as loxP sites 
flanking exon 27. The Myo10tm1a ES cells were injected into blastocysts at the University of Michigan Transgenic 
Core Facility and chimeras were bred to C57BL/6 mice to get germline transmission. Chimeras were also bred 
to C57BL/6 mice expressing FLPo recombinase to delete the KO-first cassette and generate the Myo10tm1c condi-
tional allele. Genotyping was used to confirm generation of the Myo10tm1c allele and to select breeders that did not 
carry FLPo. To generate a true genomic KO allele for Myo10 (Myo10tm1d) while maintaining the C57BL/6 back-
ground, mice carrying the Myo10tm1c conditional allele were crossed with C57BL/6 J β-actin global Cre deleter 
mice (strain #019099, Jax). Genotyping was used to confirm deletion of exon 27 and to select breeders that did not 
carry β-actin Cre. Sperm from C57BL/6 mice carrying the Myo10tm1a allele will be deposited in the Mutant Mouse 
Resource and Research Center following publication (www.mmrrc.org). Myo10m1J mice on a congenic C57BL/6 J 
background were obtained from Jax (strain #024583).
Genotyping. The presence and zygosity of the Myo10tm1a, Myo10tm1c and Myo10tm1d alleles were verified by 
PCR using genomic DNA purified from tissue collected at either the time of dissection or P10. Primers were 
designed for the locations denoted in Fig. 1B. PCR products were visualized by gel electrophoresis using 2% aga-
rose containing 1X SYBR Safe DNA Gel Stain (Invitrogen, Catalog #S33102). Two primer sets were used for the 
Myo10tm1a allele: 30/31 identifies the lacZ cassette, while 24/29 determine zygosity – the Myo10tm1a allele produces 
a 567 bp band while the wild-type allele produces a 426 bp band. For the Myo10tm1c substrain, the 24/29 primer 
set will only produce a 265 bp band if the allele is present, whereas 24/25 will result in a 567 bp for Myo10tm1c and 
a 426 bp band for wild-type. Presence of the Myo10tm1d allele was verified using 24/27, which produces a 1400 bp 
band for wild-type and a 450 bp band for the Myo10tm1d allele. As a secondary measure of Myo10tm1d homozygo-
sity, primer sets 26/27 were also used, which results in no product in mice homozygous for the Myo10tm1d allele. 
Genotyping primers used are as follows:
#24 (loxP2/3 Fwd): 5′-GTCCTCAGTCCCACATGACAA-3′;
#25 (loxP2/3 Rev): 5′-GAAGTCCCTTTAAGCAGCCC-3′;
#26 (Flank loxP3 Fwd): 5′-GGGAGCCGACATCAGTGTAG-3′;
#27 (Flank loxP3 Rev): 5′-ACCGCCCATATTACACCCCT-3′;
#28 (FRT1 Fwd): 5′-CTGGGTTTGGTCCTCAGTCC-3′;
#29 (FRT1 Rev): 5′-ATAGGAACTTCGGTTCCGGC-3′;
#30 (lacZ Fwd): 5′-GGTGAAGTGCCTCTGGATGT-3′;
#31 (lacZ Rev): 5′-CAAAAATCCATTTCGCTGGT-3′.
Two primer sets were designed for genotyping the Myo10m1J allele:
J-M10-E25d: 5′-CTTCGACGAGATCGACGAGTGCGTC-3′;
J-M10-E25-3-1: 5′-GTAAGGGTCCTCCTCGGATGAGTC-3′;
J-M10-E25-5: 5′-CAGGAGTTCTTGGAGTCGCTCAAC-3′;
J-M10-E25-3-2: 5′-CTCTTCGCCCGAAATCTCGCTC-3′.
To confirm homozygotes, a 5′-primer with an 8 bp deletion, J-M10-E25d, was used along with J-M10-E25-3-1; 
wild-type produces a 290 bp band while m1J produces nothing. The primers outside of 8 bp deletion, J-M10-E25-5 
and J-M10-E25-3-2 are used to distinguish wild-type and heterozygotes. The difference between wild-type and 
m1J products (99 and 91 bp respectively) was detected using a 2% agarose gel.
Immunoblotting. Because P5 mouse brain expresses both full-length and headless Myo10, it was used in 
immunoblotting to verify loss of Myo10 in the Myo10tm1a/tm1a mice and their derivatives. Because Myo10 protein 
undergoes rapid degradation, whole brain (including cerebellum) was weighed and immediately added to 1X 
Laemmli sample buffer (50 mM Tris, pH 7.4, 2% SDS, 6% glycerol, 0.1 M DTT and 0.25% bromophenol blue) 
at 500 μL/10 mg wet brain weight and boiled for 15 min. Samples were thoroughly aspirated to dissociate the 
tissue and the lysates were centrifuged at 20,000 g for 30 min at RT. Serial dilutions of each lysate was subject 
to SDS-PAGE using a Bolt 4–12% Bis-Tris Plus gel (ThermoFisher). Final loading volumes were adjusted for 
immunoblot based on quantification of the actin band from Coomassie blue stained gels. After SDS-PAGE, 
lysates were transferred to nitrocellulose at room temperature using a Hoefer TE22 transfer tank containing 
Transfer Buffer (20 mM Tris, 200 mM Glycine, 20% Methanol, and 0.1% SDS) set to 100 V for 1.5 hrs, followed 
by blocking for 30 min in PBS containing 10% dried milk powder. Membranes were then incubated for 30 min in 
PBS containing 5% dried milk and 0.25% Tween 20 plus 1 μg/mL rabbit anti-Myo10 (Sigma #HPA024223; Lot# 
A60694) and 1 μg/mL mouse anti-actin (Abcam #ab3280), followed by three 5 min washes in PBS with 0.5% 
Tween 20. Membranes were then incubated for 30 min in PBS containing 5% dried milk, 0.25% Tween 20, 0.05% 
SDS with IRDye 680LT goat anti-rabbit IgG and IRDye 800CW Donkey anti-mouse IgG (LI-COR #926–68021 
and #926-32212), both at 0.1 μg/mL. Following three 5 min washes, blots were imaged on a LI-COR Odyssey 
CLx infrared imaging system. Brightness/Contrast for the Myo10 (700 nm) and Actin (800 nm) channels was 
uniformly adjusted across the full blot using LI-COR ImageStudio software, then exported for final processing 
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in ImageJ. The actin channel was displayed in red and overlaid onto the Myo10 channel, which was converted 
to inverted gray scale.
Embryo dissections. Timed pregnancies were monitored by plug check, with noon on the morning a plug 
was present defined as E 0.5. Pregnant females were euthanized by CO2 asphyxiation. Intact uterine horns were 
removed from the abdominal cavity and placed in a 10-cm petri dish containing PBS. After separating embryos 
from each other, the uterine wall, Reichert’s membrane, visceral yolk sac and placenta were trimmed away. Tail 
tissue was taken to verify genotype. Whole embryos were then placed in 4% paraformaldehyde overnight at 4 °C 
prior to imaging.
Preparation of eye cups and retinal flat mounts. Due to the high level of exencephaly, it was difficult to 
reliably obtain Myo10 null pups with littermate controls from het-het matings. We therefore bred Myo10tm1d/tm1d  
males with Myo10+/tm1d females to obtain greater numbers of Myo10tm1d/tm1d pups and compared these to 
Myo10+/+ controls from separate matings. To obtain eyes, P5 pups were euthanized by decapitation. The eyes 
were immediately enucleated and incubated in 4% paraformaldehyde in PBS for 1 hr at RT. After trimming excess 
scleral connective tissue, the cornea and iris was removed using spring scissors. To remove the lens, four small 
incisions were made across the corneoscleral divide, which prevents retinal detachment when removing the lens 
from the eyecup. Once the lens and elements of the vitreous were removed, the four incisions (90° to each other 
about the eyecup) were extended through the sclera to the optic nerve, resulting in a retina with a 4-petal shape 
that can be flat-mounted. A round-blade scalpel was used to sever the retina from its junction point with the cor-
nea. The sclera was then removed by gently peeling the retina off and severing the optic nerve.
Retinas were then permeabilized in 0.5% Triton X-100 in PBS for 20 min at RT, followed by 3 washes with 
PBS. Retinas were blocked in 5% bovine serum albumin (Sigma #A4503) in PBS for 4 hrs at RT, followed by 
overnight incubation at 4 °C with 0.3 μg/mL of rat anti-PECAM-1 (BD Biosciences #550274) in 5% BSA/PBS. 
After 3 washes with 0.1% Triton X-100 in PBS and 2 washes with PBS, retinas were incubated with 2 μg/mL of 
Alexa Fluor 488-conjugated donkey anti-rat IgG secondary antibody (Invitrogen #A21208) in 5% BSA/PBS and 
counterstained with 13.2 nM Alexa Fluor 568-labeled phalloidin and 22 μM DAPI (Molecular Probes #A12380 
and #D3571). Retinas were then flat-mounted with “Gelvatol,” a semi-hardening mounting media: 10% polyvinyl 
alcohol (Sigma #P8136), 20% glycerol (Sigma #P5516) and 0.2% N-propyl gallate (Sigma #02370) in 0.1 M Tris, 
pH 8.5.
Hematoxylin and eosin staining of embryo sections. Mouse embryos at E16.5 were fixed in 4% PFA 
overnight, embedded in paraffin, and 5 μm sections were cut and mounted on slides. The sections were depa-
raffinized by xylene and stained by H&E solution. Nanozoomer 2.0 RS scanner (Hamamatsu) was used to image 
the slides.
Image Acquisition and Image Analysis. An Olympus FluoView FV1200 confocal system was used for 
fluorescent images of retinal flat mounts. Tiled Z-stack images of entire retinas were captured with a 20X (0.75 
NA) lens. To visualize filopodia, Z-stacks were collected with a 60X (1.35 NA) oil immersion lens and a Z step 
of 0.2 μm, then tiled to assemble an image of the entire vascular front along each petal of a flat-mounted retina. 
Maximum intensity projections for both 20X and 60X tiled images were then stitched using the Paired Stitching 
plug-in for FIJI/ImageJ99. Images of embryos, tails, and eyes were acquired using a Leica M205 FA equipped with 
a MicroPublisher CCD camera (Q Imaging).
Statistics. Error bars in figures and ± symbols indicate standard deviations unless indicated otherwise. 
P-values were calculated using two-tailed Student’s t-tests.
Data Availability Statement. The datasets generated during and/or analyzed during the current study are 
available from the corresponding author upon request.
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